Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Blau Farmaceutica's share price for the quarter that ended in Dec. 2024 was R$13.15. Blau Farmaceutica's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 178 Mil. Therefore, Blau Farmaceutica's market cap for the quarter that ended in Dec. 2024 was R$2,337 Mil.
Blau Farmaceutica's quarterly market cap
increased
from Jun. 2024 (R$1,864 Mil) to Sep. 2024 (R$2,344 Mil) but then
declined
from Sep. 2024 (R$2,344 Mil) to Dec. 2024 (R$2,337 Mil).
Blau Farmaceutica's annual market cap
declined
from Dec. 2022 (R$4,681 Mil) to Dec. 2023 (R$2,916 Mil) and
declined
from Dec. 2023 (R$2,916 Mil) to Dec. 2024 (R$2,337 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Blau Farmaceutica's Enterprise Value for Today is R$2,270 Mil.
Blau Farmaceutica Market Cap Historical Data
The historical data trend for Blau Farmaceutica's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Blau Farmaceutica's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blau Farmaceutica's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's Market Cap distribution charts can be found below:
* The bar in red indicates where Blau Farmaceutica's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Blau Farmaceutica's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blau Farmaceutica (BSP:BLAU3) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Blau Farmaceutica Market Cap Related Terms
Thank you for viewing the detailed overview of Blau Farmaceutica's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:BLAU3 has been successfully added to your 